Ion Beam Applications (XBRU:IBAB) Total Liabilities : €491.3 Mil (As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Ion Beam Applications Total Liabilities?

Ion Beam Applications's Total Liabilities for the quarter that ended in Dec. 2023 was €491.3 Mil.

Ion Beam Applications's quarterly Total Liabilities increased from Dec. 2022 (€507.95 Mil) to Jun. 2023 (€523.34 Mil) but then declined from Jun. 2023 (€523.34 Mil) to Dec. 2023 (€491.32 Mil).

Ion Beam Applications's annual Total Liabilities increased from Dec. 2021 (€420.16 Mil) to Dec. 2022 (€507.95 Mil) but then declined from Dec. 2022 (€507.95 Mil) to Dec. 2023 (€491.32 Mil).

Ion Beam Applications Total Liabilities Historical Data

The historical data trend for Ion Beam Applications's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ion Beam Applications Total Liabilities Chart

Ion Beam Applications Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

313.77

369.17

420.16

507.95

491.32

Ion Beam Applications Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															420.16	452.81	507.95	523.34	491.32

Ion Beam Applications Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ion Beam Applications's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	452.601	+	(29.01	+	9.705
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	491.3

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	597.528	-	106.212
	=	491.3

Ion Beam Applications's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	452.601	+	(29.01	+	9.705
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	491.3

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	597.528	-	106.212
	=	491.3

Ion Beam Applications Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ion Beam Applications's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ion Beam Applications (XBRU:IBAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ion Beam Applications SA (XBRU:IBAB) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

IOBCF:USA 0GZK:UK IOB:Germany

Address

Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348

Website

https://www.iba-worldwide.com

Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and the Rest of the World, with REst-of-World sales generating the largest proportion of revenue.

Ion Beam Applications (XBRU:IBAB) Headlines

No Headlines